Company intelligence / Profile preview

Dover

Frederica, Delaware, USA

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

ILC Dover is a global leader in flexible containment solutions and single-use technologies for the life sciences industry, supporting manufacturing safety, sterility, and efficiency for biologics, small molecules, and advanced therapies. Clinical results are not applicable as it is a technology/enabling company.

Modalities: Biologic manufacturingCell therapy manufacturingGene therapy manufacturingSmall molecule manufacturingDevice manufacturing
Industry: Chemicals & Materials

Partnerships

Partners with major global pharma, CDMO, and biotech companies, unnamed for confidentiality; serves 1,000+ customers in life sciences

Beyond the preview

Go deeper on Dover.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dover.

Explore the full profile